PacBio announced the Vega system, the company’s first benchtop long-read sequencing platform, delivering all the functionality of the Revio system into a compact, lower-throughput benchtop platform.
Aptamer Group announced that a genetic medicines customer has selected to progress to the final commercial development phase for Optimer delivery vehicles.
Cherwell is to highlight its range of products for environmental monitoring and process validation in sterile medicinal product manufacturing and how these complement other products within its parent company AnalytiChem’s Life Science segment.
Sonrai is working to bring its innovative cloud-based AI technology to the Henri & Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital (MGH), enabling vast and complex data for more meaningful insights.
Bespak and Orbia Advance Corporation announced a collaboration intended to accelerate the transition to climate-friendly inhalers utilising Orbia Fluor & Energy Materials’ low global warming potential propellant known as Zephex 152a.
SGS technicians at the Wavre laboratory have paired the Malvern Spraytec system with the Mighty Runt actuator to precisely assess how factors like device actuation – including pump velocity and force – and droplet size impact drug delivery.
Biosynth announced that its board of directors has appointed Matt Gunnison as the company's new chief executive officer and a member of the board of directors, effective immediately.
ARC Innovation announced the successful $5.1 million funding round of Starget Pharma, a startup specialising in precise cancer diagnosis and targeted radiotherapy.
iotaSciences announced the upcoming launch of its newly developed Single-Cell Cloning Platform XT at the Cell 2024 event in London (UK) from November 6-8, 2024.
